These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15868938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As(2)O(3)), but are not the main mechanism of As(2)O(3)-resistance in acute promyelocytic leukemia cells.
    Takeshita A, Shinjo K, Naito K, Matsui H, Shigeno K, Nakamura S, Horii T, Maekawa M, Kitamura K, Naoe T, Ohnishi K, Ohno R.
    Leukemia; 2003 Mar; 17(3):648-50. PubMed ID: 12646961
    [No Abstract] [Full Text] [Related]

  • 9. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L.
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
    Yang CH, Kuo ML, Chen JC, Chen YC.
    Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748
    [Abstract] [Full Text] [Related]

  • 11. Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide.
    Chen J, Cheng J, Yi J, Xie B, Lin L, Liu Z, Zhao H, Wang B, Ai Z, Yang Y, Wei H.
    Leuk Res; 2016 Nov; 50():116-122. PubMed ID: 27736728
    [Abstract] [Full Text] [Related]

  • 12. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S, Bengtzen S, Paul A, Christensson B, Paul C.
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G, Cappellini A, Tazzari PL, Falà F, Billi AM, Manzoli L, Cocco L, Martelli AM.
    J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.
    Bernardini S, Nuccetelli M, Noguera NI, Bellincampi L, Lunghi P, Bonati A, Mann K, Miller WH, Federici G, Lo Coco F.
    Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines.
    Zhao YY, Yu L, Liu BL, He XJ, Zhang BY.
    Mol Med Rep; 2015 Nov; 12(5):7335-43. PubMed ID: 26459009
    [Abstract] [Full Text] [Related]

  • 20. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR, Jena RK.
    Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.